بیوژنریک
Sign in to saveAlso known as Biosimilar Pharmaceutical, Biosimilar Pharmaceuticals
A biosimilar (also known as follow-on biologic or subsequent entry biologic) is a biologic medical product that is almost an identical copy of an original product that is manufactured by a different company. Biosimilars are officially approved versions of original "innovator" products and can be manufactured when the original product's patent expires. Reference to the innovator product is an integral component of the approval.
Research
7,496 papers- Streamlining biosimilar development based on 20 years' experience.Expert opinion on biological therapy · 2024
- Understanding Biosimilar Insulins - Development, Manufacturing, and Clinical Trials.Journal of diabetes science and technology · 2023
- Why is there no biosimilar of Erbitux®?Journal of pharmaceutical and biomedical analysis · 2023
- Biosimilar medicines - Review.The International journal of risk & safety in medicine · 2016
- [Biosimilar drugs in oncology].Bulletin du cancer · 2016
via PubMed
Wikidata facts
- Subclass of
- biopharmaceutical
Show 1 more fact
- different from
- generic drug
via Wikidata · CC0